43 related articles for article (PubMed ID: 31077237)
1. Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer.
Guo Y; Yang N; Li G; Yin X; Dong L
J Immunol Res; 2022; 2022():4379216. PubMed ID: 35647204
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer.
Zhong Y; Zhuang Z; Mo P; Shang Q; Lin M; Gong J; Huang J; Mo H; Huang M
Evid Based Complement Alternat Med; 2021; 2021():5557873. PubMed ID: 34567213
[TBL] [Abstract][Full Text] [Related]
3. The Immune-Related Gene ELF3 is a Novel Biomarker for the Prognosis of Ovarian Cancer.
Xu H; Wang H; Li G; Jin X; Chen B
Int J Gen Med; 2021; 14():5537-5548. PubMed ID: 34531679
[TBL] [Abstract][Full Text] [Related]
4. Using bioinformatics approaches to investigate driver genes and identify BCL7A as a prognostic gene in colorectal cancer.
Chao JY; Chang HC; Jiang JK; Yang CY; Chen FH; Lai YL; Lin WJ; Li CY; Wang SC; Yang MH; Lin YF; Cheng WC
Comput Struct Biotechnol J; 2021; 19():3922-3929. PubMed ID: 34306573
[TBL] [Abstract][Full Text] [Related]
5. BCL7C suppresses ovarian cancer growth by inactivating mutant p53.
Huang C; Hao Q; Shi G; Zhou X; Zhang Y
J Mol Cell Biol; 2021 May; 13(2):141-150. PubMed ID: 33306126
[TBL] [Abstract][Full Text] [Related]
6. SLC25A11 serves as a novel prognostic biomarker in liver cancer.
Pan G; Wang R; Jia S; Li Y; Jiao Y; Liu N
Sci Rep; 2020 Jun; 10(1):9871. PubMed ID: 32555317
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-like modifier-activating enzyme 7 as a marker for the diagnosis and prognosis of breast cancer.
Lin M; Li Y; Qin S; Jiao Y; Hua F
Oncol Lett; 2020 Apr; 19(4):2773-2784. PubMed ID: 32218830
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer.
Yang D; Jiao Y; Li Y; Fang X
PeerJ; 2020; 8():e8252. PubMed ID: 31998552
[TBL] [Abstract][Full Text] [Related]
9. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
10. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
11. BCL7A as a novel prognostic biomarker for glioma patients.
Liu J; Gao L; Ji B; Geng R; Chen J; Tao X; Cai Q; Chen Z
J Transl Med; 2021 Aug; 19(1):335. PubMed ID: 34362400
[TBL] [Abstract][Full Text] [Related]
12. BCL7A protein expression in normal and malignant lymphoid tissues.
Ramos-Medina R; Montes-Moreno S; Maestre L; Cañamero M; Rodríguez-Pinilla M; Martínez-Torrecuadrada J; Piris MÁ; Majid A; Dyer MJ; Pulford K; Roncador G
Br J Haematol; 2013 Jan; 160(1):106-9. PubMed ID: 23043359
[No Abstract] [Full Text] [Related]
13. Low EIF2B5 expression predicts poor prognosis in ovarian cancer.
Hou L; Jiao Y; Li Y; Luo Z; Zhang X; Pan G; Zhao Y; Yang Z; He M
Medicine (Baltimore); 2020 Jan; 99(5):e18666. PubMed ID: 32000373
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion.
Li J; Li S; Chen R; Lu X
Oncotarget; 2017 Feb; 8(6):9672-9685. PubMed ID: 28039463
[TBL] [Abstract][Full Text] [Related]
15. Low BCL7A expression predicts poor prognosis in ovarian cancer.
Sun Z; Sun L; He M; Pang Y; Yang Z; Wang J
J Ovarian Res; 2019 May; 12(1):41. PubMed ID: 31077237
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
